litlas
ログインアカウント作成

E. Michael Lewiecki

2002–2025 年に発表

136
論文数
30,962
被引用数
83
h 指数
132
i10 指数

被引用数

E. Michael Lewiecki の年別被引用数1995 年: 被引用 2 件1996 年: 被引用 1 件1998 年: 被引用 4 件2000 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 11 件2005 年: 被引用 18 件2006 年: 被引用 86 件2007 年: 被引用 68 件2008 年: 被引用 133 件2009 年: 被引用 129 件2010 年: 被引用 170 件2011 年: 被引用 170 件2012 年: 被引用 174 件2013 年: 被引用 149 件2014 年: 被引用 144 件2015 年: 被引用 175 件2016 年: 被引用 179 件2017 年: 被引用 238 件2018 年: 被引用 253 件2019 年: 被引用 807 件2020 年: 被引用 1,180 件2021 年: 被引用 923 件2022 年: 被引用 782 件2023 年: 被引用 685 件2024 年: 被引用 1,234 件2025 年: 被引用 593 件2026 年: 被引用 20 件1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません2001〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,064 件、この内訳の 20.8%中国: 引用元論文 917 件、この内訳の 9.3%イギリス: 引用元論文 734 件、この内訳の 7.4%カナダ: 引用元論文 485 件、この内訳の 4.9%イタリア: 引用元論文 473 件、この内訳の 4.8%ドイツ: 引用元論文 398 件、この内訳の 4%オーストラリア: 引用元論文 389 件、この内訳の 3.9%スイス: 引用元論文 309 件、この内訳の 3.1%フランス: 引用元論文 298 件、この内訳の 3%日本: 引用元論文 277 件、この内訳の 2.8%ベルギー: 引用元論文 273 件、この内訳の 2.8%オランダ: 引用元論文 273 件、この内訳の 2.8%
0%20.8%その他 30.4%

機関

分野

  • Medicine78%
  • Biochemistry, Genetics and Molecular Biology14.1%
  • Engineering2.7%
  • Health Professions1%
  • Dentistry0.7%
  • Immunology and Microbiology0.5%
  • その他3%

トピック

  • Bone health and osteoporosis research19.5%
  • Bone health and treatments9.2%
  • Bone Metabolism and Diseases8.8%
  • Hip and Femur Fractures4.7%
  • Parathyroid Disorders and Treatments4.1%
  • Bone and Joint Diseases3.6%
  • その他50.1%

共著者

全論文

検索で開く
  1. The clinician’s guide to prevention and treatment of osteoporosis

    著者: Meryl S. LeBoff, S. L. Greenspan, Karl Insogna, E. Michael Lewiecki, Kenneth G. Saag, Andrea Singer, Ethel S. Siris - Osteoporosis International 2022 被引用: 1,339

  2. Romosozumab Treatment in Postmenopausal Women with Osteoporosis

    著者: Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi, Neil Binkley, E. J. Czerwiński, Serge Ferrari, Lorenz C. Hofbauer, Edith Lau, E. Michael Lewiecki, Akimitsu Miyauchi, Cristiano A. F. Zerbini, Cassandra E. Milmont, Li Chen, Judy Maddox, Paul Meisner, Cesar Libanati, Andreas Grauer - New England Journal of Medicine 2016 被引用: 1,726

  3. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

    著者: Pauline M. Camacho, Steven M. Petak, Neil Binkley, Dima L. Diab, Leslie S. Eldeiry, Azeez Farooki, Steven T. Harris, Daniel L. Hurley, Jenny Kelly, E. Michael Lewiecki, Rachel Pessah‐Pollack, Michael R. McClung, Sunil J. Wimalawansa, Nelson B. Watts - Endocrine Practice 2020 被引用: 1,109

  4. Clinician’s Guide to Prevention and Treatment of Osteoporosis

    著者: Felicia Cosman, Suzanne M. Jan de Beur, Meryl S. LeBoff, E. Michael Lewiecki, Bobo Tanner, Susan Randall, R. Lindsay - Osteoporosis International 2014 被引用: 4,082

  5. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016-Executive Summary

    著者: Pauline M. Camacho, Steven M. Petak, Neil Binkley, B.L. Clarke, Steven T. Harris, Daniel L. Hurley, Michael Kleerekoper, E. Michael Lewiecki, Paul D. Miller, Harmeet S. Narula, Rachel Pessah‐Pollack, Vin Tangpricha, Sunil J. Wimalawansa, Nelson B. Watts - Endocrine Practice 2016 被引用: 1,144

  6. Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality

    著者: Chor‐Wing Sing, Tzu‐Chieh Lin, Sharon Bartholomew, J. Simon Bell, Corina Bennett, Kebede Beyene, Pauline Bosco‐Lévy, Brian D. Bradbury, Amy Hai Yan Chan, Manju Chandran, Cyrus Cooper, Maria de Ridder, Caroline Y. Doyon, C. Droz‐Perroteau, Ganga Ganesan, Sirpa Hartikainen, Jenni Ilomäki, Han Eol Jeong, Douglas P. Kiel, Kiyoshi Kubota, Edward Chia‐Cheng Lai, Jeff Lange, E. Michael Lewiecki, Julian Lin, Jiannong Liu, Joe Maskell, Mirhelen Mendes de Abreu, James O’Kelly, Nobuhiro Ooba, Alma B Pedersen, Albert Prats‐Uribe, Daniel Prieto‐Alhambra, Simon Xiwen Qin, Ju‐Young Shin, Henrik Toft Sørensen, Kelvin Bryan Tan, Tracy Thomas, Anna‐Maija Tolppanen, Katia Verhamme, Grace Hsin‐Min Wang, Sawaeng Watcharathanakij, Stephen J. Wood, Ching‐Lung Cheung, Ian Chi Kei Wong - Journal of Bone and Mineral Research 2023 被引用: 526

  7. A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

    著者: E. Michael Lewiecki, Tomasz Blicharski, Stefan Goemaere, Kurt Lippuner, Paul Meisner, Paul D. Miller, Akimitsu Miyauchi, Judy Maddox, Li Chen, S. Horlait - The Journal of Clinical Endocrinology & Metabolism 2018 被引用: 317

  8. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics

    著者: Christopher Shuhart, Swan Sim Yeap, Paul A. Anderson, Lawrence G. Jankowski, E. Michael Lewiecki, Leslie R. Morse, Harold N. Rosen, David R. Weber, Babette S. Zemel, John Shepherd - Journal of Clinical Densitometry 2019 被引用: 512

  9. Clinical Use of Quantitative Computed Tomography and Peripheral Quantitative Computed Tomography in the Management of Osteoporosis in Adults: The 2007 ISCD Official Positions

    著者: Klaus Engelke, Judith E. Adams, Gabriele Armbrecht, Peter Augat, César E. Bogado, Mary Bouxsein, Dieter Felsenberg, Masako Ito, Sven Prevrhal, Didier Hans, E. Michael Lewiecki - Journal of Clinical Densitometry 2008 被引用: 614

  10. One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

    著者: E. Michael Lewiecki, Rajani Dinavahi, Marise Lazaretti-Castro, Peter R. Ebeling, Jonathan D. Adachi, Akimitsu Miyauchi, Evelien Gielen, Cassandra E. Milmont, Cesar Libanati, Andreas Grauer - Journal of Bone and Mineral Research 2018 被引用: 192

  11. Romosozumab and antiresorptive treatment: the importance of treatment sequence

    著者: Felicia Cosman, David L. Kendler, Bente Langdahl, Benjamin Z. Leder, E. Michael Lewiecki, Akimitsu Miyauchi, Maria Rojeski, Michele McDermott, Mary Oates, Cassandra E. Milmont, Cesar Libanati, Serge Ferrari - Osteoporosis International 2022 被引用: 111

  12. Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

    著者: E. Michael Lewiecki, Jesse D. Ortendahl, J. Vanderpuye-Orgle, Andreas Grauer, Jorge Arellano, J. A. Leo Lemay, Amanda L. Harmon, Michael S. Broder, Andrea Singer - JBMR Plus 2019 被引用: 229

  13. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

    著者: Nelson B. Watts, Pauline M. Camacho, E. Michael Lewiecki, Steven M. Petak - Endocrine Practice 2021 被引用: 163

  14. Denosumab in Postmenopausal Women with Low Bone Mineral Density

    著者: Michael R. McClung, E. Michael Lewiecki, Stanley Cohen, Michael A. Bolognese, Grattan C. Woodson, Alfred H. Moffett, Munro Peacock, Paul D. Miller, Samuel Lederman, Charles H. Chesnut, Douglas Lain, Alan Kivitz, Donna Holloway, Charlie Zhang, Mark Peterson, Pirow Bekker - New England Journal of Medicine 2006 被引用: 1,215

  15. Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services

    著者: Willem F. Lems, Julien Paccou, Jianfa Zhang, Nicholas R. Fuggle, Manju Chandran, Nicholas C. Harvey, Cyrus Cooper, M K Javaid, Serge Ferrari, Kristina Åkesson, Kristina Åkesson, Maria Luisa Brandi, Manju Chandran, Thierry Chevalley, Cyrus Cooper, Patrice Fardellone, Stefan Goemaere, Nicholas C. Harvey, Gerold Holzer, M K Javaid, Willem F. Lems, E. Michael Lewiecki, G. Lyritis, Nicola Napoli, Julien Paccou, S. Silverman, M. Sosa, Thierry Thomas - Osteoporosis International 2021 被引用: 136

  16. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update Executive Summary

    著者: Pauline M. Camacho, Steven M. Petak, Neil Binkley, Dima L. Diab, Leslie S. Eldeiry, Azeez Farooki, Steven T. Harris, Daniel L. Hurley, Jenny Kelly, E. Michael Lewiecki, Rachel Pessah‐Pollack, Michael R. McClung, Sunil J. Wimalawansa, Nelson B. Watts - Endocrine Practice 2020 被引用: 202

  17. Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance

    著者: E. Michael Lewiecki, Neil Binkley, Sarah Morgan, Christopher Shuhart, Bruno Muzzi Camargos, John Carey, Catherine M. Gordon, Lawrence G. Jankowski, Joon Kiong Lee, William D. Leslie - Journal of Clinical Densitometry 2016 被引用: 321

  18. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024

    著者: Felicia Cosman, E. Michael Lewiecki, Richard Eastell, Peter R. Ebeling, Suzanne M. Jan de Beur, Bente Langdahl, Yumie Rhee, Ghada El‐Hajj Fuleihan, Douglas P. Kiel, John T. Schousboe, João Lindolfo Cunha Borges, Angela M. Cheung, Adolfo Díez‐Pérez, Peyman Hadji, Sakae Tanaka, Friederike Thomasius, Weibo Xia, Steven R. Cummings - Journal of Bone and Mineral Research 2024 被引用: 102

  19. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

    著者: Aliya Khan, David A. Hanley, René Rizzoli, Jens Bollerslev, J. E. M. Young, Lars Rejnmark, Rajesh V. Thakker, P D'Amour, Terri Paul, Stan Van Uum, M. Zakaria Shrayyef, David Goltzman, S. Kaiser, Natalie E. Cusano, Roger Bouillon, Leif Mosekilde, A W Kung, Sudhaker D. Rao, Sanjay Kumar Bhadada, B.L. Clarke, Jue Liu, Quan‐Yang Duh, E. Michael Lewiecki, Francisco Bandeira, Richard Eastell, Claudio Marcocci, Shonni J. Silverberg, Robert Udelsman, K. Shawn Davison, John T. Potts, Maria Luisa Brandi, John P. Bilezikian - Osteoporosis International 2016 被引用: 538

  20. Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

    著者: Michael R. McClung, Steven T. Harris, Paul D. Miller, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, David L. Kendler, Chui Kin Yuen, E. Michael Lewiecki - The American Journal of Medicine 2012 被引用: 453

  21. Benefits and Risks of Bisphosphonate Therapy for Osteoporosis

    著者: Sundeep Khosla, John P. Bilezikian, David W. Dempster, E. Michael Lewiecki, Paul D. Miller, Robert M. Neer, Robert R. Recker, Elizabeth Shane, Dolores Shoback, John T. Potts - The Journal of Clinical Endocrinology & Metabolism 2012 被引用: 285

  22. Hip fracture trends in the United States, 2002 to 2015

    著者: E. Michael Lewiecki, Nicole C. Wright, Jeffrey R. Curtis, Ethel S. Siris, Robert F. Gagel, Kenneth G. Saag, Andrea Singer, Polgar Steven, Robert A. Adler - Osteoporosis International 2017 被引用: 279

  23. Observations following discontinuation of long-term denosumab therapy

    著者: Michael R. McClung, R.B. Wagman, Paul D. Miller, A. Wang, E. Michael Lewiecki - Osteoporosis International 2017 被引用: 220

  24. Vertebral Fractures: Clinical Importance and Management

    著者: David L. Kendler, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, S. T. Harris, Michael R. McClung, Paul D. Miller, John T. Schousboe, Chui Kin Yuen, E. Michael Lewiecki - The American Journal of Medicine 2015 被引用: 315